NEBIVOLOL HYDROCHLORIDE LOADED NANOSTRUCTURED LIPID CARRIERS AS TRANSDERMAL DELIVERY SYSTEM:-PART 2:- HYDROGEL PREPARATION, EVALUATION AND PERMEATION STUDY

Nebivolol hydrochloride (NEB), is a third generation highly selective β 1 -blocker, it has an antihypertensive properties. Its elimination half-life is around 10 hrs while its oral bioavailability is about 12%. The objective of the current study was to develop nanostructured lipid carriers (NLCs) for transdermal delivery of (NEB). Through the preparation, characterization and conducting of an in vitro study for (NEB) loaded (NLCs), the formulation of NEB-NLCs based hydrogel using different types of gelling agents was introduced. Moreover, the incorporation of lipid nanoparticles into carbapol 934 as hydrogel base in different formulations was described in this study. The optimized formula (350 mg Glyceryl monostearate, 150 mg oleic acid, 2% (W/W) span 80, and 2% (W/W) Cremophor EL) was tested for entrapment efficiency, particle size and loading capacity then incorporated into hydrogel for expedient transdermal application. A number of measures were implemented for the NEB-NLCs based hydrogel, the results for the optimized formula were found to be as the following: particle size 228 nm, polydispersity index 0.3, zeta potential -29mV, pH 7.05 viscosity 7210cps, spreadability 6 cm, drug content 95%, and Ex Vitro skin permeation 90.8%. The transmission electron microscopy (TEM) and the optical microscope study revealed almost spherical shaped nanoparticles. Nebivolol  based  hydrogel  demonstrated no  skin  irritation  and  showed a  prolong  release  for up  to  24 hrs.  The flux for the permeation study through rat skin was found to be (143μg/cm 2 /hr). Carbapol 934 was used as a gelling agent; the obtained formula gave evidence for good spreadability, homogeneity and rheological behavior. In conclusion, the data obtained from this study illustrated a successful development of NEB-NLCs-based hydrogel in the increase of the encapsulation efficiency of colloidal lipid carriers. The advantages of the colloidal lipid carriers of the improved performance  were in terms of stability and provides a sustaining NEB transdermal effect. Keywords: Nebivolol hydrochloride; Nanostructured lipid carriers, Hydrogel, Transdermal delivery

[1]  M. Sosabowski Clarke’s Analysis of Drugs and Poisons , 2018 .

[2]  E. Ghazy,et al.  Nebivolol Hydrochloride Loaded Nanostructured Lipid Carriers as Transdermal Delivery System: Part 1: Preparation, Characterization and In Vitro Evaluation , 2016, Al Mustansiriyah Journal of Pharmaceutical Sciences.

[3]  Dong Li,et al.  Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo , 2016, Drug delivery.

[4]  D. Gomes,et al.  Nanostructured lipid carriers loaded with tributyrin as an alternative to improve anticancer activity of all-trans retinoic acid , 2015, Expert review of anticancer therapy.

[5]  Khizar Abbas,et al.  In vitro evaluation of transdermal patches of flurbiprofen with ethyl cellulose. , 2014, Acta poloniae pharmaceutica.

[6]  A. Rasedee,et al.  Zerumbone-loaded nanostructured lipid carriers: preparation, characterization, and antileukemic effect , 2013, International journal of nanomedicine.

[7]  K. Pathak,et al.  Development of thermodynamically stable nanostructured lipid carrier system using central composite design for zero order permeation of Econazole nitrate through epidermis , 2013, Pharmaceutical development and technology.

[8]  E. Souto,et al.  Nanomedicines for ocular NSAIDs: safety on drug delivery. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[9]  J. Pardeike,et al.  Nanostructured lipid carriers (NLC) in cosmetic dermal products. , 2007, Advanced drug delivery reviews.

[10]  Huibi Xu,et al.  Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[11]  B. Röder,et al.  Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[12]  R. Asija,et al.  Liquid chromatographic method development and validation for assay and dissolution of nebivolol hydrochloride in tablet dosage form , 2014 .

[13]  S. S. Agrawal,et al.  Formulation and evaluation of chitosan based bioadhesive transdermal drug delivery systems of lisinopril for prolonged drug delivery , 2013 .

[14]  R. Manavalan,et al.  Nanoparticle: An overview of preparation and characterization , 2011 .

[15]  A. Moffat,et al.  Comprar Clarke's Analysis of Drugs and Poisons | Jo Watts | 9780853697114 | Pharmaceutical Press , 2011 .

[16]  Peeyush Kumar,et al.  A REVIEW ON NOVEL LIPID BASED NANOCARRIERS , 2010 .

[17]  Susan Budavari,et al.  The Merck index : an encyclopedia of chemicals, drugs, and biologicals , 1983 .